Skip to main content
Erschienen in: Diabetologia 9/2014

01.09.2014 | Commentary

Evidence-based estimation of insulin resistance

verfasst von: John R. Petrie

Erschienen in: Diabetologia | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Insulin resistance is a complex phenotype. Surrogate markers based on peripheral glucose and insulin (and in some cases NEFA) concentrations can provide, at best, moderate approximations to direct physiological measurements (Pearson r values 0.6–0.7). Where the focus is solely on insulin resistance, the evidence reviewed in the paper by Otten et al in this issue (DOI: 10.​1007/​s00125-014-3285-x) suggests that surrogate markers based on fasting samples alone are as valid as those that require multiple samples and an oral glucose load. This provides an evidence base for simplifying the design of some clinical studies.
Literatur
1.
Zurück zum Zitat Hiatt WR, Kaul S, Smith RJ (2013) The cardiovascular safety of diabetes drugs – insights from the rosiglitazone experience. N Engl J Med 369:1285–1287PubMedCrossRef Hiatt WR, Kaul S, Smith RJ (2013) The cardiovascular safety of diabetes drugs – insights from the rosiglitazone experience. N Engl J Med 369:1285–1287PubMedCrossRef
2.
4.
Zurück zum Zitat DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed
5.
Zurück zum Zitat Hills SA, Balkau B, Coppack SW et al (2004) The EGIR-RISC study (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 47:566–570 Hills SA, Balkau B, Coppack SW et al (2004) The EGIR-RISC study (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 47:566–570
6.
Zurück zum Zitat Wagenknecht LE, Mayer EJ, Rewers M et al (1995) The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. Ann Epidemiol 5:464–472PubMedCrossRef Wagenknecht LE, Mayer EJ, Rewers M et al (1995) The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. Ann Epidemiol 5:464–472PubMedCrossRef
7.
Zurück zum Zitat Kozakova M, Natali A, Dekker J et al (2013) Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study. Arterioscler Thromb Vasc Biol 33:1409–1417PubMedCrossRef Kozakova M, Natali A, Dekker J et al (2013) Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study. Arterioscler Thromb Vasc Biol 33:1409–1417PubMedCrossRef
8.
Zurück zum Zitat Petrie JR, Malik MO, Balkau B et al (2013) Euglycemic clamp insulin sensitivity and longitudinal systolic blood pressure: role of sex. Hypertension 62:404–409PubMedCrossRef Petrie JR, Malik MO, Balkau B et al (2013) Euglycemic clamp insulin sensitivity and longitudinal systolic blood pressure: role of sex. Hypertension 62:404–409PubMedCrossRef
9.
Metadaten
Titel
Evidence-based estimation of insulin resistance
verfasst von
John R. Petrie
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 9/2014
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3322-9

Weitere Artikel der Ausgabe 9/2014

Diabetologia 9/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.